Literature DB >> 33374290

Similarities and Differences in Extracellular Vesicle Profiles between Ischaemic Stroke and Myocardial Infarction.

Laura Otero-Ortega1, Elisa Alonso-López1, María Pérez-Mato1, Fernando Laso-García1, Mari Carmen Gómez-de Frutos1, Luke Diekhorst1, María Laura García-Bermejo2, Elisa Conde-Moreno2, Blanca Fuentes1, María Alonso de Leciñana1, Eduardo Armada3, Lorena Buiza-Palomino4, Exuperio Díez-Tejedor1, María Gutiérrez-Fernández1.   

Abstract

Extracellular vesicles (EVs) are involved in intercellular signalling through the transfer of molecules during physiological and pathological conditions, such as ischaemic disease. EVs might therefore play a role in ischaemic stroke (IS) and myocardial infarction (MI). In the present study, we analysed the similarities and differences in the content of circulating EVs in patients with IS and MI. This prospective observational study enrolled 140 participants (81 patients with IS, 37 with MI and 22 healthy controls [HCs]). We analysed the protein and microRNA content from EVs using proteomics and reverse transcription quantitative real-time polymerase chain reaction and compared it between the groups. In the patients with IS and MI, we identified 14 common proteins. When comparing IS and MI, we found differences in the protein profiles (apolipoprotein B, alpha-2-macroglobulin, fibronectin). We also found lower levels of miR-340 and miR-424 and higher levels of miR-29b in the patients with IS and MI compared with the HCs. Lastly, we found higher miR-340 levels in IS than in MI. In conclusion, proteomic and miRNA analyses suggest a relationship between circulating EV content and the patient's disease state. Although IS and MI affect different organs (brain and heart) with distinct histological characteristics, certain EV proteins and miRNAs appear to participate in both diseases, while others are present only in patients with IS.

Entities:  

Keywords:  exosomes; extracellular vesicles; ischaemia; miRNAs; myocardial infarction; proteins; stroke

Year:  2020        PMID: 33374290      PMCID: PMC7824002          DOI: 10.3390/biomedicines9010008

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  44 in total

1.  Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time.

Authors:  R Suades; T Padró; J Crespo; I Ramaiola; V Martin-Yuste; M Sabaté; J Sans-Roselló; A Sionis; L Badimon
Journal:  Int J Cardiol       Date:  2015-09-12       Impact factor: 4.164

Review 2.  Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity.

Authors:  Paul M Ridker
Journal:  Nutr Rev       Date:  2007-12       Impact factor: 7.110

3.  Alteration of microRNA 340-5p and Arginase-1 Expression in Peripheral Blood Cells during Acute Ischemic Stroke.

Authors:  Hanna Yoo; Jinkwon Kim; Ae-Ri Lee; Ji-Min Lee; Ok-Joon Kim; Jin-Kyeoung Kim; Seung-Hun Oh
Journal:  Mol Neurobiol       Date:  2018-08-15       Impact factor: 5.590

Review 4.  Brain-Heart Interactions During Ischemic Processes: Clinical and Experimental Evidences.

Authors:  Alexandre Méloux; Yannick Béjot; Luc Rochette; Yves Cottin; Catherine Vergely
Journal:  Stroke       Date:  2019-12-20       Impact factor: 7.914

5.  Circulating microvesicle number, function and small RNA content vary with age, gender, smoking status, lipid and hormone profiles.

Authors:  Anoop K Enjeti; Anita Ariyarajah; Angel D'Crus; Michael Seldon; Lisa F Lincz
Journal:  Thromb Res       Date:  2017-04-20       Impact factor: 3.944

6.  APOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke.

Authors:  R Akinyemi; H K Tiwari; D K Arnett; B Ovbiagele; M R Irvin; K Wahab; F Sarfo; V Srinivasasainagendra; A Adeoye; R T Perry; A Akpalu; C Jenkins; O Arulogun; M Gebregziabher; L Owolabi; R Obiako; E Sanya; M Komolafe; M Fawale; P Adebayo; G Osaigbovo; T Sunmonu; P Olowoyo; I Chukwuonye; Y Obiabo; A Onoja; J Akinyemi; G Ogbole; S Melikam; R Saulson; M Owolabi
Journal:  Acta Neurol Scand       Date:  2017-10-03       Impact factor: 3.209

7.  Association of High-sensitivity C-reactive Protein with Patient Prognosis Following Mechanical Thrombectomy for Acute Ischemic Stroke.

Authors:  Seonggon Kim; Ho J Yi; Dong H Lee; Jae H Sung
Journal:  Curr Neurovasc Res       Date:  2020       Impact factor: 1.990

8.  Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens.

Authors:  Emily N Prendergast; Marcos Abraão de Souza Fonseca; Felipe Segato Dezem; Jenny Lester; Beth Y Karlan; Houtan Noushmehr; Xianzhi Lin; Kate Lawrenson
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.752

Review 9.  Extracellular Vesicles: How Drug and Pathology Interfere With Their Biogenesis and Function.

Authors:  Daniela Cesselli; Pietro Parisse; Aneta Aleksova; Claudia Veneziano; Celeste Cervellin; Andrea Zanello; Antonio Paolo Beltrami
Journal:  Front Physiol       Date:  2018-10-01       Impact factor: 4.566

Review 10.  Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.

Authors:  Lei Chang; Jie Ni; Ying Zhu; Bairen Pang; Peter Graham; Hao Zhang; Yong Li
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

View more
  3 in total

Review 1.  Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications.

Authors:  Karin Hochrainer; Wei Yang
Journal:  Circ Res       Date:  2022-04-14       Impact factor: 23.213

Review 2.  Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain.

Authors:  Paolo Gelosa; Laura Castiglioni; Joanna Rzemieniec; Majeda Muluhie; Marina Camera; Luigi Sironi
Journal:  J Mol Med (Berl)       Date:  2021-10-21       Impact factor: 5.606

Review 3.  Potential Applications and Functional Roles of Exosomes in Cardiometabolic Disease.

Authors:  Sergio Ayala-Mar; Belén Rodríguez-Morales; Pedro Chacón-Ponce; José González-Valdez
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.